YOLFTbeta
53

LACMED

5341 · KLSE · Healthcare / Medical Devices

0.72MYR+0.03 (+3.60%)

Price History

Full chart

Market Stats

Previous Close0.695
Open0.715
Day Range0.715 – 0.755
52-Week Range0.65 – 1.33
Volume1.97M
Market Cap284.00M
P/E (TTM)14.20
Forward P/E12.39
EPS0.05
Dividend Yield0.92%
50-Day Avg0.7547
200-Day Avg0.8478

About

LAC Med Berhad engages in the distribution, supply, and integration of medical devices, diagnostic equipment, and digital health solutions for diagnostic purposes in Malaysia and Indonesia. The company offers diagnostic equipment, radiographic, ultrasound, magnetic resonance imaging (MRI), as well as software systems and maintenance services. It serves hospitals, clinics, and healthcare providers. The company was incorporated in 2003 and is headquartered in Petaling Jaya, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Yoon Poh Liew
  • Employees100
  • HeadquartersG-03A-3, Plaza Kelana Jaya, Petaling Jaya, Malaysia, 47301, Malaysia
  • Websitehttps://www.lacmed.com

Leadership

  • Mr. Yoon Poh LiewGroup CEO & Executive Director · b. 1981
  • Mr. Chong Chet HongDeputy Chief Executive Officer · b. 1981
  • Ms. Yain Peng TheanChief Financial Officer · b. 1968
  • Ms. Mei Peng ChooChief People Officer · b. 1966
  • Mr. Sheau San SumSenior Vice President of Service Operations · b. 1977
  • Mr. Peng Ting TehChief Commercial Officer · b. 1980

Financials

Income Statement

Currency: MYR2022-12-312023-12-312024-12-312025-12-31
Total Revenue106.64M150.35M183.22M201.63M
Growth (%)-+40.98%+21.86%+10.05%
Cost of Revenue76.88M109.32M137.74M143.15M
Gross Profit29.77M41.03M45.48M58.48M
Gross Margin27.91%27.29%24.82%29.00%
Operating Expense10.07M16.57M17.87M27.02M
Operating Income19.70M24.46M27.61M31.47M
Operating Margin18.47%16.27%15.07%15.61%
EBITDA18.19M27.00M27.92M32.86M
EBITDA Margin17.06%17.96%15.24%16.30%
Net Income13.06M20.74M20.40M21.94M
Net Income Margin12.25%13.80%11.13%10.88%
Interest Expense832.00K1.01M494.17K766.00K
Interest Expense % of Total Revenue0.78%0.67%0.27%0.38%

Balance Sheet

Currency: MYR2022-12-312023-12-312024-12-312025-12-31
Total Assets103.25M139.61M128.11M236.24M
Total Liabilities78.13M99.75M80.21M117.38M
Total Equity25.12M39.87M47.76M118.80M
Cash23.83M30.45M15.84M64.89M
Net Debt11.07M-4.37M-

Cash Flow

Currency: MYR2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.87M22.61M30.67M589.00K
Capital Expenditure226.88K894.32K501.00K12.16M
Free Cash Flow2.65M21.72M30.17M-11.57M
Dividends Paid3.40M4.00M18.50M5.00M
FCF to OCF92.10%96.04%98.37%-1964.35%
Dividend Paid to FCF128.53%18.42%61.32%-43.22%

Earnings

Report DateDec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---
EPS Actual0.020.000.01
Surprise---
Timing---

Key Statistics & Ratios

Market Cap284.00M
Enterprise Value254.78M
Trailing P/E14.20
Forward P/E12.39
Price / Sales1.56
Price / Book2.32
EPS0.05
Book Value0.306
Revenue (TTM)181.67M
Gross Profit (TTM)50.37M
EBITDA27.05M
Profit Margin10.02%
Operating Margin14.28%
Return on Equity20.69%
Return on Assets8.88%
Shares Outstanding400.00M
Shares Float88.19M
Dividend Yield0.92%
Dividend Rate0.01
Payout Ratio16.09%

Dividends

20261×
0.01May 26, 2026